{"as_of":"2026-08-10T13:41:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:a00a08966eeb1d3b24c5dfdcf434bf35566f0b7dc5e28a2060ef2057c50f9cd0","coverage":[{"denominator":0,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":1,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-10T06:31:04.303077+00:00","state":"measured"},{"denominator":1,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":1,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-08T20:18:09.982465Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"pith","source_observed_at":"2026-08-08T20:18:10.170252Z","state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2303.17615","last_updated":"2024-01-30T21:09:48Z","snapshot_observed_at":"2026-08-09T05:02:17.368406Z","submitted_at":"2023-03-30T07:40:50Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","version":2},"cited_work":{"arxiv_id":"2303.17615","doi":null,"metadata_source":"pith","pith_arxiv_id":"2303.17615","snapshot_observed_at":"2026-08-08T20:18:10.170252Z","title":"Utilizing Reinforcement Learning for de novo Drug Design","venue":"q-bio.BM","work_id":"0c8efddd-e310-42c2-b115-6e58336429c0","year":2023},"citing_paper":{"arxiv_id":"2502.05107","last_updated":"2025-02-07T17:28:10Z","snapshot_observed_at":"2026-08-10T11:33:10.124414Z","submitted_at":"2025-02-07T17:28:10Z","title":"3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery","version":1},"reference_index":76,"source":"arxiv_source","source_observed_at":"2026-08-08T20:18:09.982465Z"},"links":{"cited_paper":"/paper/2303.17615","citing_paper":"/paper/2502.05107"},"observation_digest":"sha256:d441470ee874d949829797fd9e5b8a7b79c81c4b641d2942aa476d6e75d9b39c","observation_id":"d323661d-bb53-43a3-9a4c-496702d57ffa","resolution":{"observed_at":"2026-08-08T20:18:10.174588Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-10T06:31:04.303077+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"state":"measured"}}],"links":{"evidence":"/evidence","html":"/paper/2303.17615/citation-record","integrity":"/paper/2303.17615/integrity","json":"/paper/2303.17615/citation-record.json","paper":"/paper/2303.17615"},"outbound":[],"paper":{"arxiv_id":"2303.17615","last_updated":"2024-01-30T21:09:48Z","latest_version":2,"primary_category":"q-bio.BM","snapshot_observed_at":"2026-08-09T05:02:17.368406Z","submitted_at":"2023-03-30T07:40:50Z","title":"Utilizing Reinforcement Learning for de novo Drug Design"},"reference_resolution":{"displayed":0,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":0,"verified_exact":0,"verified_fuzzy":0},"total_outbound_references":0},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-10T06:31:04.303077+00:00","source":"crossref"},{"observed_at":"2026-08-10T06:30:57.382061+00:00","source":"retraction_watch"}],"thesis":"As of 10 August 2026, this Paper Citation Record lists 0 of 0 outbound references and 1 inbound Pith citation observation for arXiv:2303.17615."}